Stock vs Stock Comparison

Lockheed Martin Corporation vs Arcosa, Inc.

LMT wins the Tale of the Tape 5–4.

LMT$512.03
ACA

🏆 Tale of the Tape

54
LMTACA
6.7%Profitability (Net Margin)7.2%
25.7xValuation (P/E)28.3x
15.2%Efficiency (ROIC)6.2%
6/9Health (Piotroski F)8/9
3.6Safety (Altman Z)
5.6%Growth (Rev YoY)12.2%
1.18Risk (Sharpe 1Y)
7.90xBalance Sheet (D/E)0.89x
4.38%FCF Yield

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Fundamentals

MetricLMTACA
Market Cap$122.3B$5.9B
P/E Ratio25.7x28.3x
Forward P/E16.5x22.4x
P/B16.29x2.23x
Dividend Yield2.60%0.17%
Beta0.100.96

Quantitative Metrics

MetricLMTACA
DCF Fair Value$705.80$99.96
DCF Upside+13.9%
Piotroski F6/98/9
Altman Z3.61
Beneish M-2.71-2.48
FCF Yield4.38%
Net Debt/EBITDA1.9x2.3x
ROIC15.2%6.2%
WACC7.5%
ROIC – WACC7.8pp
Gross Margin10.2%22.4%
Net Margin6.7%7.2%
Rev Growth YoY5.6%12.2%
Sharpe (1Y)1.18
Max Drawdown 3Y
FCF Payout Ratio45%6%

LMT Price

Loading chart...

ACA Price

Loading chart...

ETF Exposure

LMT found in:

SCHD4.82%
ITA3.92%
XAR2.54%
XLI1.99%
VIS1.53%
DVY1.17%
SDY0.89%
VFMO0.59%
MGV0.59%
ARKX0.57%
QUS0.57%
VIG0.47%
VTV0.46%
SCHV0.45%
VYM0.45%
SPYV0.37%
IWD0.30%
RSP0.26%
VONV0.24%
SCHX0.22%
VFQY0.21%
SCHB0.20%
VFMV0.18%
VOO0.17%
VTI0.17%
SPLG0.17%
IVV0.17%
SPY0.17%
URTH0.16%
VONE0.16%
SPTM0.15%
ITOT0.15%
ACWI0.14%
ONEO0.14%
IWF0.13%
VONG0.10%
VT0.09%

ACA found in:

SLYG0.45%
SPSM0.35%
SLYV0.25%
VTWO0.18%
VFMO0.15%
VBR0.14%
VGK0.12%
VYMI0.10%
VIS0.09%
SPDW0.08%
VB0.08%
VXF0.08%
VEA0.06%
VSGX0.06%
CWI0.05%
VEU0.05%
VXUS0.04%
SPTM0.01%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

LMT vs ACA: Head-to-Head Analysis

Lockheed Martin Corporation (LMT) and Arcosa, Inc. (ACA) represent two companies in the Industrials sector. In our quantitative Tale of the Tape scoring, LMT leads 5–4 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, LMT generates a return on invested capital (ROIC) of 15.2% compared to ACA's 6.2%. This suggests LMT is more effective at deploying capital to generate shareholder returns.

LMT appears in 37 ETFs tracked by SecuritiesDB, while ACA appears in 18 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, LMT or ACA?

Our quantitative analysis compares LMT and ACA across nine fundamental dimensions. LMT wins the Tale of the Tape 5–4. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are LMT and ACA correlated?

Correlation data is not yet available for this pair. Check back after both stocks have sufficient trading history.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.